Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
Public ClinicalTrials.gov record NCT02066545. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Acne Vulgaris
Study identification
- NCT ID
- NCT02066545
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Maruho Co., Ltd.
- Industry
- Enrollment
- 327 participants
Conditions and interventions
Conditions
Interventions
- CLS001 Topical Gel Drug
- CLS001 Topical Gel Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Oct 31, 2014
- Completion
- Not listed
- Last update posted
- Sep 16, 2015
Started 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 11
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Encino Research Center | Encino | California | 91436 | — |
| Skin Surgery Medical Group, Inc. | San Diego | California | 92117 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Skin Care Research, Inc. | Boca Raton | Florida | 33486 | — |
| Belleair Research Center | Pinellas Park | Florida | 33781 | — |
| Moore Clinical Research, Inc. | Tampa | Florida | 33609 | — |
| Kenneth R. Beer, MD, PA | West Palm Beach | Florida | 33401 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Academic Dermatology Associates | Albuquerque | New Mexico | 87106 | — |
| Manhattan Dermatology & Cosmetic Center | New York | New York | 10017 | — |
| Derm Research Center of New York, Inc. | Stony Brook | New York | 11790 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Premier Research | Austin | Texas | 78705 | — |
| J & S Studies, Inc. | College Station | Texas | 77845 | — |
| Progressive Clinical Research, PA | San Antonio | Texas | 78229 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02066545, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 16, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02066545 live on ClinicalTrials.gov.